| Therapeutic Shoes Inc | |
|
718 Beulahs Lane, Idaho Falls, ID 83401 | |
| (208) 524-1995 | |
| (208) 524-1995 |
| Full Name | Therapeutic Shoes Inc |
|---|---|
| Type | Facility |
| Speciality | Durable Medical Equipment & Medical Supplies |
| Location | 718 Beulahs Lane, Idaho Falls, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205874914 | NPI | - | NPPES |
| P0854 | Other | BC | |
| 1350425 | Medicaid | ID | |
| 82505 | Other | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | P085 (Idaho) | Secondary |
| 332B00000X | Durable Medical Equipment & Medical Supplies | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Therapeutic Shoes Inc 718 Beulahs Lane, Idaho Falls, ID 83401 Ph: (208) 524-1995 | Therapeutic Shoes Inc 718 Beulahs Lane, Idaho Falls, ID 83401 Ph: (208) 524-1995 |
News Archive
Detroit area physical therapist Jay Jha, 45, pleaded guilty today to participating in a conspiracy to defraud the Medicare program of approximately $18.3 million, Assistant Attorney General Lanny A. Breuer of the Criminal Division, U.S. Attorney Terrence I. Berg of the Eastern District of Michigan and Daniel R. Levinson, Inspector General of the Department of Health & Human Services (HHS) announced.
AM-Pharma B.V., a biopharmaceutical company focused on the preclinical and clinical development of Alkaline Phosphatase (AP) for treatment of severe inflammatory diseases, today announced that it has raised €29.2m in Series D financing.
Patients with stage III colon cancer treated with 5-FU-based chemotherapy after complete surgical removal of their tumor after 1995 had improved overall survival with no change in time to recurrence compared to patients treated before 1995. In contrast, patients with stage II colon cancer treated after 1995 had longer time to recurrence and time from recurrence to death compared to those patients treated prior to 1995, according to Mayo Clinic and Gr Hospitalier Pitie-Salpetriere, Paris, researchers.
For the second quarter of 2011, Sorin Group expects revenues to grow 1 - 2% compared to the same period of 2010 and a net profit of approximately €14 - 16 million.
Leishmaniasis is one of the most underreported and insufficiently monitored diseases in the world affecting mainly the poorest and most disadvantaged people on the Indian Subcontinent, Latin America and East Africa. The disease is caused by tiny parasites, the Leishmania, and transmitted by the bite of an infected sandfly.
› Verified 7 days ago